TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
A new orallyadministered poly ADPribose polymerase PARP inhibitor Niraparib has been launched by the Janssen Pharmaceutical Companies of Johnson Johnson
A new ultrasensitive nanoscale optical probe has been developed by the researchers at UC Santa Cruz that can monitor the bioelectric activity of neurons and other excitable cells
A new medication Ofev nintedanib has been launched by Boehringer Ingelheim for the treatment of patients with chronic fibrosing Interstitial Lung Diseases ILDs with a progressive phenotype
Genentech a member of the Roche Group announced that a new lymphoma medicine under the name Gazyva obinutuzumab has been launched to treat adults with lupus nephritis
SpringWorks Therapeutics has launched its experimental drug nirogacestat for the treatment of adult patients with rare and progressive cancer known as desmoid tumors
An investigational prophylactic vaccine has been launched by the Janssen Pharmaceutical Companies of Johnson Johnson Janssen for the prevention of respiratory syncytial virus RSVmediated lower respiratory tract disease
Pegzilarginase an investigational therapy has been launched by Aeglea BioTherapeutics for the treatment of Arginase Deficiency ARGD Pegzilarginase is an enhanced human arginase that is intended for use as an enzyme replacement therapy in patients to reduce the elevated blood arginine levels
The University of North Carolina UNC Lineberger Comprehensive Cancer Center researchers have discovered a hyperactive cell that contributes to tumor growth in primary effusion lymphoma and a potential treatment strategy to block down its downstream effects
Dicerna Pharmaceuticals announced that its investigational drug DCRPHXC is used for the treatment of patients with primary hyperoxaluria type PH a rare genetic liver disorder that often results in kidney failure
USbased biotechnology company PanTheryx in partnership with Zuellig Pharma a healthcare company in Asia announced the launch of innovation of DiaResQ for diarrhea relief in Cambodia
